Get the Stockscreener App
0.792
0.44%
-0.0035
Clearmind Medicine Inc stock is traded at $0.792, with a volume of 375.12K.
It is down -0.44% in the last 24 hours and down -20.80% over the past month.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
See More
Previous Close:
$0.7955
Open:
$0.79
24h Volume:
375.12K
Relative Volume:
0.42
Market Cap:
$4.31M
Revenue:
-
Net Income/Loss:
$-6.78M
P/E Ratio:
-0.0185
EPS:
-42.6996
Net Cash Flow:
$-4.67M
1W Performance:
-20.80%
1M Performance:
-20.80%
6M Performance:
-21.52%
1Y Performance:
-41.76%
1-Day Range:
$0.7561
$0.84
1-Week Range:
$0.75
$1.20
52-Week Range:
$0.75
$2.18
Clearmind Medicine Inc Stock (CMND) Company Profile
Compare CMND with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CMND
Clearmind Medicine Inc
|
0.7876 | 4.35M | 0 | -6.78M | -4.67M | -42.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.63 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.39 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.26 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
821.78 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.80 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Clearmind Medicine Inc Stock (CMND) Latest News
Can Clearmind Medicine Inc. (CWY0) stock double in coming yearsQuarterly Trade Summary & Community Consensus Trade Alerts - newser.com
Is Clearmind Medicine Inc. (CWY0) stock a buy for dividend portfolios2025 Historical Comparison & Stock Market Timing Techniques - newser.com
How sentiment analysis helps forecast Clearmind Medicine Inc.Market Performance Summary & Risk Controlled Swing Alerts - newser.com
Price momentum metrics for Clearmind Medicine Inc. explained2025 EndofYear Setup & Technical Confirmation Alerts - newser.com
Published on: 2025-11-03 01:01:42 - newser.com
Why Clearmind Medicine Inc. stock is trending among retail tradersMarket Trend Report & Weekly Stock Breakout Alerts - newser.com
Will Clearmind Medicine Inc. (CWY0) stock hit analyst forecastsMarket Performance Summary & Weekly High Conviction Ideas - newser.com
Intraday pattern recognizer results for Clearmind Medicine Inc.Portfolio Update Report & Precise Buy Zone Identification - newser.com
Is Clearmind Medicine Inc. stock supported by strong fundamentalsJuly 2025 Breakouts & High Conviction Trade Alerts - newser.com
Will Clearmind Medicine Inc. (CWY0) stock outperform Dow Jones2025 Price Action Summary & Detailed Earnings Play Alerts - newser.com
Best data tools to analyze Clearmind Medicine Inc. stockMarket Movement Recap & Long-Term Investment Growth Plans - newser.com
What earnings margins imply for Clearmind Medicine Inc. (CWY0) stockWeekly Earnings Recap & Daily Oversold Bounce Ideas - newser.com
Is Clearmind Medicine Inc. stock positioned for long term growth2025 Dividend Review & Community Supported Trade Ideas - newser.com
Historical volatility pattern of Clearmind Medicine Inc. visualized2025 Valuation Update & Fast Exit/Entry Strategy Plans - newser.com
What momentum shifts mean for Clearmind Medicine Inc.Earnings Recap Summary & Daily Entry Point Alerts - newser.com
What dividend safety score for Clearmind Medicine Inc. stockPortfolio Gains Report & Risk Managed Investment Strategies - newser.com
Applying big data sentiment scoring on Clearmind Medicine Inc.Quarterly Risk Review & Long-Term Capital Growth Strategies - newser.com
Clearmind Medicine files patent for cocaine addiction treatment By Investing.com - Investing.com Canada
Clearmind Medicine files patent for cocaine addiction treatment - Investing.com
Clearmind Medicine Advances Fight Against Cocaine Addiction with Publication of U.S. Patent Application for Its Non-Hallucinogenic Neuroplastogen MEAI Therapy - The Manila Times
Clearmind Medicine Advances Fight Against Cocaine Addiction With Publication of U.S. Patent Application for Its Non-Hallucinogenic Neuroplastogen MEAI Therapy - 富途牛牛
Using data models to predict Clearmind Medicine Inc. stock movementEarnings Trend Report & Breakout Confirmation Alerts - newser.com
Volatility clustering patterns for Clearmind Medicine Inc.July 2025 Patterns & Free Community Consensus Stock Picks - newser.com
How Clearmind Medicine Inc. stock responds to policy changesJuly 2025 Technicals & Entry Point Strategy Guides - newser.com
Is Clearmind Medicine Inc. (CWY0) stock inflation resilientJuly 2025 Patterns & Fast Entry and Exit Trade Plans - newser.com
How Clearmind Medicine Inc. (CWY0) stock trades after earningsJuly 2025 Earnings & Reliable Entry Point Alerts - newser.com
Published on: 2025-10-31 00:59:13 - newser.com
Strategies to average down on Clearmind Medicine Inc.Weekly Earnings Recap & High Win Rate Trade Alerts - newser.com
Clearmind Advances Fight Against Cocaine Addiction With Publication of U.S. Patent Application for Its Non-Hallucinogenic Neuroplastogen MEAI Therapy - 富途牛牛
Clearmind Medicine Inc Stock (CMND) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.29%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):